IFP Advisors, Inc - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,274
-82.2%
295
-50.0%
0.00%
Q2 2023$7,166
+37.2%
590
+100.0%
0.00%
Q1 2023$5,222
+104340.0%
2950.0%0.00%
Q4 2022$5
-99.9%
2950.0%0.00%
Q3 2022$5,0000.0%2950.0%0.00%
Q2 2022$5,000
-50.0%
295
-50.0%
0.00%
Q1 2022$10,000
+100.0%
590
+100.0%
0.00%
Q4 2021$5,0000.0%2950.0%0.00%
Q3 2021$5,000
-16.7%
2950.0%0.00%
Q2 2021$6,000
+50.0%
2950.0%0.00%
Q1 2021$4,0000.0%2950.0%0.00%
Q4 2020$4,0002950.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2018$37,000
-15.9%
1,425
-25.0%
0.00%0.0%
Q3 2018$44,000
+144.4%
1,900
+90.0%
0.00%
+100.0%
Q3 2017$18,0001,0000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders